Skip to main content

Exkivity Prices, Coupons and Patient Assistance Programs

Exkivity (mobocertinib) is a member of the EGFR inhibitors drug class and is commonly used for Non-Small Cell Lung Cancer.

The cost for Exkivity oral capsule 40 mg is around $28,177 for a supply of 120 capsules, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Exkivity is available as a brand name drug only, a generic version is not yet available. View generic Exkivity availability for more details.

Exkivity prices

Oral Capsule

Quantity Per unit Price
120 $234.81 $28,177.25

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Exkivity Coupons, Copay Cards and Rebates

Exkivity offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Exkivity Takeda Oncology Co-Pay Assistance Program

Eligible commercially insured patients may pay as little as $0 per prescription per year; co-pay card can be renewed every 12 months subject to continued eligibility; for additional information contact the program at 844-817-6468 option 2.

Applies to:
Exkivity
Number of uses:
per prescription per year

Form more information phone: 844-817-6468 or Visit website

Exkivity Takeda Oncology Co-Pay Assistance Program Rebate

Eligible commercially insured patients may submit a rebate if unable to use the offer at the pharmacy when already enrolled in the program; patient must pay in full for their prescription before submitting the rebate at https://www.patientrebateonline.com; for additional information contact the program at 844-817-6468 option 2.

Applies to:
Exkivity
Number of uses:
One rebate per prescription fill

Form more information phone: 844-817-6468 or Visit website

Patient Assistance & Copay Programs for Exkivity

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: Patient Access Network Foundation (PAN)

Eligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Exkivity (mobocertinib) Capsule

More information please phone: 866-316-7263 Visit Website

Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.